Investigating the relationship between infertility and depression in women


  • Maryam Karimpour Department of Clinical Biochemistry, Fasa University of Medical Sciences, Fasa, Iran.
  • Behnoosh Miladpour Department of Clinical Biochemistry, Fasa University of Medical Sciences, Fasa, Iran.



Infertility, Ddepression, women, AMH, FSH


Depression plays a clear and undeniable role in infertility. In this study, we investigated the status of depression and the levels of fertility hormones in infertile women. One hundred infertile women and 50 fertile controls participated in this study. The serum levels of cortisol, anti-mullerian hormone (AMH), luteinizing hormone (LH), follicle-stimulating hormone (FSH) and inhibin B markers were measured using electro-quantitative luminescence and ELISA techniques. The results showed a significant difference between the case and control groups in terms of the serum levels of LH, FSH, and AMH (P-value˂ 0.05). Depression was significantly associated with AMH in infertile women (P-value = 0.049). AMH and FSH showed a significant difference between the two groups of depressed fertile and depressed infertile women (P-value = 0.005, P-value = 0.042, respectively). In addition, there was a significant difference between the two groups regarding depression status (P-value = 0.003). We concluded that depression might affect AMH, FSH levels, and infertility. As a result, examining all the important and relevant markers of infertility and paying attention to the psychological conditions of women are highly important. Thus, it is possible to prioritize these cases to improve couples' fertility.


Berg, B. J., & Wilson, J. F. (1991). Psychological functioning across stages of treatment for infertility. Journal of Behavioral Medicine, 14(1), 11-26.

Boivin, J., Griffiths, E., & Venetis, C. A. (2011). Emotional distress in infertile women and failure of assisted reproductive technologies: meta-analysis of prospective psychosocial studies. BMJ, 342, d223.

Breen, K. M., & Karsch, F. J. (2004). Does cortisol inhibit pulsatile luteinizing hormone secretion at the hypothalamic or pituitary level? Endocrinology, 145(2), 692-698.

Broer, S., Dolleman, M., Opmeer, B., Fauser, B., Mol, B., & Broekmans, F. (2011). AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis. Human Reproduction Update, 17(1), 46-54.

Cesta, C. E., Johansson, A. L., Hreinsson, J., Rodriguez‐Wallberg, K. A., Olofsson, J. I., Holte, J., Wramsby, H., Wramsby, M., Cnattingius, S., & Skalkidou, A. (2018). A prospective investigation of perceived stress, infertility‐related stress, and cortisol levels in women undergoing in vitro fertilization: influence on embryo quality and clinical pregnancy rate. Acta Obstetricia et Gynecologica Scandinavica, 97(3), 258-268.

Chen, T.H., Chang, S.P., Tsai, C.F., & Juang, K.D. (2004). Prevalence of depressive and anxiety disorders in an assisted reproductive technique clinic. Human Reproduction, 19(10), 2313-2318.

Chhibber, A., Woody, S. K., Rumi, M. K., Soares, M. J., & Zhao, L. (2017). Estrogen receptor β deficiency impairs BDNF–5-HT2A signaling in the hippocampus of female brain: a possible mechanism for menopausal depression. Psychoneuroendocrinology, 82, 107-116.

Coccia, M. E., & Rizzello, F. (2008). Ovarian reserve. Annals of the New York Academy of Sciences, 1127(1), 27-30.

Cox, S. J., Glazebrook, C., Sheard, C., Ndukwe, G., & Oates, M. (2006). Maternal self-esteem after successful treatment for infertility. Fertility & Sterility, 85(1), 84-89.

Demyttenaere, K., Nijs, P., Evers-Kiebooms, G., & Koninckx, P. R. (1992). Coping and the ineffectiveness of coping influence the outcome of in vivro fertilization through stress responses. Psychoneuroendocrinology, 17(6), 655-665.

Dolleman, M., Verschuren, W., Eijkemans, M., Dollé, M., Jansen, E., Broekmans, F., & Van der Schouw, Y. (2013). Reproductive and lifestyle determinants of anti-Müllerian hormone in a large population-based study. The Journal of Clinical Endocrinology & Metabolism, 98(5), 2106-2115.

Domar, A. D., Broome, A., Zuttermeister, P. C., Seibel, M., & Friedman, R. (1992). The prevalence and predictability of depression in infertile women. Fertility & Sterility, 58(6), 1158-1163.

Florek, E., Piekoszewski, W., Czarnywojtek, A., Sędziak, A., Jawień, W., Dera-Szymanowska, A., Szukalska, M., Szymanowski, K., Chuchracki, M., & Ruchała, M. (2022). Differences in sex hormone levels in the menstrual cycle due to tobacco smoking—myth or reality? Endokrynologia Polska, 73(1), 16-25.

Ghaderpour, S., Ghiasi, R., Heydari, H., & Keyhanmanesh, R. (2021). The relation between obesity, kisspeptin, leptin, and male fertility. Hormone Molecular Biology and Clinical Investigation, 86(1), 330–336.

Goel, N., Innala, L., & Viau, V. (2014). Sex differences in serotonin (5-HT) 1A receptor regulation of HPA axis and dorsal raphe responses to acute restraint. Psychoneuroendocrinology, 40, 232-241.

Gourounti, K., Anagnostopoulos, F., & Vaslamatzis, G. (2011). The relation of psychological stress to pregnancy outcome among women undergoing in-vitro fertilization and intracytoplasmic sperm injection. Women’s Health, 51(4), 321-339.

Grynnerup, A. .A., Lindhard, A., & Sørensen, S. (2014). Recent progress in the utility of anti-Müllerian hormone in female infertility. Current Opinion in Obstetrics and Gynecology, 26(3), 162-167.

Gu, S., Jing, L., Li, Y., Huang, J. H., & Wang, F. (2018). Stress induced hormone and neuromodulator changes in menopausal depressive rats. Frontiers in Psychiatry, 9, 253.

Gu, S., Wang, W., Wang, F., & Huang, J. H. (2016). Neuromodulator and emotion biomarker for stress induced mental disorders. Neural Plasticity, 2016, 2609128.

Gurunath, S., Pandian, Z., Anderson, R. A., & Bhattacharya, S. (2011). Defining infertility—a systematic review of prevalence studies. Human Reproduction Update, 17(5), 575-588.

Hagen, C. P., Aksglaede, L., Sørensen, K., Mouritsen, A., Andersson, A. M., Petersen, J. H., Main, K. M., & Juul, A. (2012). Individual serum levels of anti-Müllerian hormone in healthy girls persist through childhood and adolescence: a longitudinal cohort study. Human Reproduction, 27(3), 861-866.

Han, Y., Xu, H., Feng, G., Alpadi, K., Chen, L., Wang, H., & Li, R. (2022). An online tool using basal or activated ovarian reserve markers to predict the number of oocytes retrieved following controlled ovarian stimulation: a prospective observational cohort study. Frontiers in Endocrinology, 13, 881983.

Haririan, H. R., Mohammadpour, Y., & Aghajanloo, A. (2010). Prevalence of depression and contributing factors of depression in the infertile women referred to kosar infertility center, 2009. The Iranian Journal of Obstetrics, Gynecology and Infertility, 13(2), 45-49.

Harlow, B. L., Wise, L. A., Otto, M. W., Soares, C. N., & Cohen, L. S. (2003). Depression and its influence on reproductive endocrine and menstrual cycle markers associated with perimenopause: the Harvard study of moods and cycles. Archives of General Psychiatry, 60(1), 29-36.

Hashimoto, M., Ho, G., Sugama, S., Takenouchi, T., Waragai, M., Sugino, H., Inoue, S., & Masliah, E. (2021). possible role of activin in the adiponectin paradox-induced progress of Alzheimer's Disease. Journal of Alzheimer's Disease, 81(2), 451-458.

Holley, S. R., Pasch, L. A., Bleil, M. E., Gregorich, S., Katz, P. K., & Adler, N. E. (2015). Prevalence and predictors of major depressive disorder for fertility treatment patients and their partners. Fertility & Sterility, 103(5), 1332-1339.

Lamazou, F., Fuchs, F., Grynberg, M., Gallot, V., Herzog, E., Fanchin, R., Frydman, N., & Frydman, R. (2011). Cancellation of IVF-ET cycles: poor prognosis, poor responder, or variability of the response to controlled ovarian hyperstimulation? An analysis of 142 cancellations. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction, 41(1), 41-47. .

Luliano, A., Schettini, S., Ferri, A., Colucci, P., Viggiani, L., Matera, I., & Ostuni, A. (2022). Are the follicular fluid characteristics of recovered coronavirus disease 2019 patients different from those of vaccinated women approaching in vitro fertilization? Frontiers in Physiology, 13, 840109.

Jackson-Koku, G. (2016). Beck depression inventory. Occupational Medicine, 66(2), 174-175.

KaboodMehri, R., Sorouri, Z. Z., Sharami, S. H., Bagheri, S. E., Yazdipaz, S., & Doaei, S. (2021). The association between the levels of anti-Müllerian hormone (AMH) and dietary intake in Iranian women. Archives of Gynecology and Obstetrics, 304(3), 687-694.

Kalkhoran, L. F., Bahrami, H., Farrokhi, N., Zeraati, H., & Tarahomi, M. (2011). Comparing anxiety, depression and sexual life satisfaction in two groups of fertile and infertile women in Tehran. Journal of Reproduction & Infertility, 12(2), 157-163.

Kiani, Z., Simbar, M., Hajian, S., & Zayeri, F. (2021). The prevalence of depression symptoms among infertile women: a systematic review and meta-analysis. Fertility Research and Practice, 7(1), 6.

Klein, N. A., Houmard, B. S., Hansen, K. R., Woodruff, T. K., Sluss, P. M., Bremner, W. J., & Soules, M. R. (2004). Age-related analysis of inhibin A, inhibin B, and activin a relative to the intercycle monotropic follicle-stimulating hormone rise in normal ovulatory women. The Journal of Clinical Endocrinology & Metabolism, 89(6), 2977-2981.

Kwee, J., Schats, R., McDonnell, J., Themmen, A., de Jong, F., & Lambalk, C. (2008). Evaluation of anti-Müllerian hormone as a test for the prediction of ovarian reserve. Fertility & Sterility, 90(3), 737-743.

Lamazou, F., Genro, V., Fuchs, F., Grynberg, M., Gallot, V., Achour-Frydman, N., Fanchin, R., & Frydman, R. (2011). Serum AMH level is not a predictive value for IVF in modified natural cycle: analysis of 342 cycles. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction (Paris), 40(3), 205-210.

Lambert-Messerlian, G. M., & Harlow, B. L. (2006). The influence of depression, body mass index, and smoking on serum inhibin B levels in late reproductive-aged women. The Journal of Clinical Endocrinology & Metabolism, 91(4), 1496-1500.

Lan, V. T. N., Linh, N. K., Tuong, H. M., Wong, P., & Howles, C. M. (2013). Anti-Müllerian hormone versus antral follicle count for defining the starting dose of FSH. Reproductive Biomedicine Online, 27(4), 390-399.

Iordăchescu, D. A., Paica, C. I., Boca, A. E., Gică, C., Panaitescu, A. M., Peltecu, G., Veduță, A., & Gică, N. (2021). Anxiety, difficulties, and coping of infertile women. Healthcare, 9(4):466.

Martins, M. V., Costa, P., Peterson, B. D., Costa, M. E., & Schmidt, L. (2014). Marital stability and repartnering: infertility-related stress trajectories of unsuccessful fertility treatment. Fertility & Sterility, 102(6), 1716-1722.

Massey, A. J., Campbell, B., Raine‐Fenning, N., Aujla, N., & Vedhara, K. (2014). The association of physiological cortisol and IVF treatment outcomes: a systematic review. Reproductive Medicine and Biology, 13(4), 161-176.

Matthiesen, S. M., Frederiksen, Y., Ingerslev, H. J., & Zachariae, R. (2011). Stress, distress and outcome of assisted reproductive technology (ART): a meta-analysis. Human Reproduction, 26(10), 2763-2776.

Muharam, R., Prasetyo, Y. D., Prabowo, K. A., Putri, Y. I., Maidarti, M., & Hestiantoro, A. (2022). IVF outcome with a high level of AMH: a focus on PCOS versus non-PCOS. BMC Women's Health, 22(1), 1-6.

Mutlu, M. F., Erdem, M., Erdem, A., Yildiz, S., Mutlu, I., Arisoy, O., & Oktem, M. (2013). Antral follicle count determines poor ovarian response better than anti-Müllerian hormone but age is the only predictor for live birth in in vitro fertilization cycles. Journal of Assisted Reproduction and Genetics, 30(5), 657-665.

Nakamura, K., Sheps, S., & Arck, P. C. (2008). Stress and reproductive failure: past notions, present insights and future directions. Journal of Assisted Reproduction and Genetics, 25(2-3), 47-62.

Ngai, F.-W., & Loke, A. Y. (2021). Relationships between infertility-related stress, family sense of coherence and quality of life of couples with infertility. Human Fertility, 1-13.

Pasch, L. A., Gregorich, S. E., Katz, P. K., Millstein, S. G., Nachtigall, R. D., Bleil, M. E., & Adler, N. E. (2012). Psychological distress and in vitro fertilization outcome. Fertility & Sterility, 98(2), 459-464.

Polyzos, N., & Sunkara, S. (2015). Sub-optimal responders following controlled ovarian stimulation: an overlooked group? Human Reproduction, 30(9), 2005-2008.

Ramezanzadeh, F., Aghssa, M. M., Abedinia, N., Zayeri, F., Khanafshar, N., Shariat, M., & Jafarabadi, M. (2004). A survey of relationship between anxiety, depression and duration of infertility. BMC Women's Health, 4(1), 1-7.

Roozitalab, S., Rahimzadeh, M., Mirmajidi, S. R., Ataee, M., & Saeieh, S. E. (2021). The Relationship between infertility, stress, and quality of life with posttraumatic stress disorder in infertile women. Journal of Reproduction & Infertility, 22(4), 282.

Sargolzaee, M., Moharreri, F., Arshadi, H., Javadi, K., Karimi, S., & Fayyazi-bordbar, M. (2001). Psychosexual and depression disorders in infertile female referring to Mashhad Infertility Treatment Center. Journal of Reproduction & Infertility, 2(4), 46-52.

Scheffer, J. B., Scheffer, B. B., de Carvalho, R. F., Vellez, L. T., Florencio, F., & Grynberg, M. (2014). Anti-Mullerian as predictor of reproductive outcome in infertile women: follow up. JBRA Assisted Reproduction, 18(3), 80.

Schneid-Kofman, N., & Sheiner, E. (2005). Does stress effect male infertility?--a debate. Medical science monitor : international medical journal of experimental and clinical research, 11 8, SR11-13. Medical Science Monitor, 11(8): SR11-13

Simionescu, G., Doroftei, B., Maftei, R., Obreja, B.-E., Anton, E., Grab, D., Ilea, C., & Anton, C. (2021). The complex relationship between infertility and psychological distress. Experimental and Therapeutic Medicine, 21(4), 1-1.

van Rooij, I. A., Broekmans, F. J., te Velde, E. R., Fauser, B. C., Bancsi, L. F., de Jong, F. H., & Themmen, A. P. (2002). Serum anti-Müllerian hormone levels: a novel measure of ovarian reserve. Human Reproduction, 17(12), 3065-3071.

Visser, J. A., de Jong, F. H., Laven, J. S., & Themmen, A. P. (2006). Anti-Mullerian hormone: a new marker for ovarian function. Reproduction, 131(1), 1-9.

Wang, J., Wu, X., Lai, W., Long, E., Zhang, X., Li, W., Zhu, Y., Chen, C., Zhong, X., & Liu, Z. (2017). Prevalence of depression and depressive symptoms among outpatients: a systematic review and meta-analysis. BMJ Open, 7(8), e017173.

Wang, Y., Wu, L., Yang, Z., Xu, R., Duan, Y., Lin, J., Cui, X., Fan, C., Zhou, Y., & Bao, W. (2022). Association of body mass index with serum anti-Müllerian hormone and inhibin B levels among 8323 women attending a reproductive medical center: a cross-sectional study. Endocrine, 75(1), 284-292.

Wen, J., Huang, K., Du, X., Zhang, H., Ding, T., Zhang, C., Ma, W., Zhong, Y., Qu, W., & Liu, Y. (2021). Can inhibin b reflect ovarian reserve of healthy reproductive age women effectively? Frontiers in Endocrinology, 12, 626534.

Welt, C., & Schneyer, A. (2001). Differential regulation of inhibin B and inhibin a by follicle-stimulating hormone and local growth factors in human granulosa cells from small antral follicles. The Journal of Clinical Endocrinology & Metabolism, 86(1), 330-336.




How to Cite

Karimpour, M. and Miladpour, B. (2022) “Investigating the relationship between infertility and depression in women”, Neuroscience Research Notes, 5(4), p. 158. doi: 10.31117/neuroscirn.v5i4.158.